2021-006538-38
A STUDY TO EVALUATE IF CRISABOROLE OINTMENT 2% WORKS WELL AND SAFE IN 2 YEARS AND OLDER CHINESE AND JAPANESE ECZEMA PATIENTS
Pfizer Inc.·EU Clinical Trials Register
Study focus
- Disease/Condition
- Atopic Dermatitis
Sponsor & location
- Primary sponsor
- Pfizer Inc.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
- Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Daxiii;
ICD-10 classifications
Atopic dermatitisAtopic dermatitis, unspecifiedOther atopic dermatitisAcute atopic conjunctivitisAllergic contact dermatitis
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2021-006538-38
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2021-006538-38 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc. and is currently status unknown. The study focuses on Atopic Dermatitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.